Novo Nordisk to build $4.1 billion North Carolina facility to boost output of Wegovy, Ozempic
How many existing Novo Nordisk facilities are in North Carolina?
Novo Nordisk has three existing manufacturing facilities in North Carolina, located in Clayton and Durham. These facilities employ around 1,800 workers and are responsible for fill and finish work, as well as producing the active ingredient in the company's diabetes pill Rybelsus.
What are the main products to be manufactured at the new facility?
The new Novo Nordisk facility in Clayton, North Carolina, will manufacture the company's blockbuster weight loss drug Wegovy, diabetes treatment Ozempic, and other injectable therapies. The investment aims to boost the supply of these drugs, which have experienced high demand and intermittent shortages in the U.S.
How many new jobs will the Clayton facility create?
The new Clayton facility will create 1,000 new jobs. Additionally, the construction phase of the project is expected to create an estimated 2,000 contractor jobs1.